Southeast Asias Shift Toward Biofuel Crops Tightens Food Supply and Export Capacity USChina Summit Yields Soybean and Rare Earth Deals Tariff Cut Discussions Continue Novartis Lifts FullYear Guidance on Strong Operational Momentum Senators Urged to Avoid Intervening in College Footballs Prosperous Landscape Govt Readies Major Overhaul of Tax Administration to Ensure Smooth GST Rollout Skilled Trade Pay Surges 30 Challenging Traditional College Career Path Says Recruitment Giant CEO SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Efficiency Gains DJCO Q4 2025 Earnings Strong EPS Beat Amid Sparse Disclosure NICE Q1 2026 Earnings EPS Beats Estimates by 282 as Cloud Momentum Continues CIMP Q1 2026 Earnings EPS Surpasses Estimates as Company Demonstrates Resilient Performance IO Biotech Q3 2025 Earnings EPS Beat Highlights Cost Discipline Amid Ongoing Pipeline Development Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings EPS Misses Estimates Amid Pipeline Progress Stock Rises 308 Eastman Chemical EMN Edges Higher as Support Holds Resistance in Sight Eaton Vance Diversified Equity Income Fund ETY Slightly Lower as IncomeFocused Investors Weigh Rate Outlook OFG Bancorp OFG Edges Higher as Regional Banking Sector Stabilizes United Fire Group UFCS Holds Steady Near Support Modest Gain Signifies Consolidation Suncor Energy SU Edges Lower Amid Consolidation Key Levels to Watch American Music Awards 2026 Performances Highlight Music Industrys Shifting Landscape Core Laboratories Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Decline Open Text OTEX Gains 108 as Stock Approaches Key Resistance Level Allspring Income Opportunities Fund EAD Inches Up as Support Holds Steady Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes Distribution Solutions Group DSGR Shows Modest Uptick Amid Consolidation Mizuho Financial MFG Drops 195 as Banking Sector Faces Pressure Soluna Holdings SLNH Surges Over 21 Key Levels to Watch After the Breakout Emera EMA Holds Near Key Support Amid Flat Trading Session Verastem VSTM Declines 25 as Biotech Sector Headwinds Persist